Efficacy of camptothecin analog DX-8951f (Exatecan Mesylate) on human pancreatic cancer in an orthotopic metastatic model.

吉西他滨 医学 原发性肿瘤 胰腺癌 内科学 转移 胰腺肿瘤 癌症研究 肿瘤科 癌症 体内 喜树碱 病理 化学 生物 生物技术 有机化学
作者
Fangxian Sun,Akiko Tohgo,Michael Bouvet,Shigeo Yagi,Rounak Nassirpour,A. R. Moossa,Robert M. Hoffman
出处
期刊:PubMed 卷期号:63 (1): 80-5 被引量:57
链接
标识
摘要

We determined the antitumor and antimetastatic efficacy of the camptothecin analogue DX-8951f in an orthotopic metastatic mouse model of pancreatic cancer. DX-8951f showed efficacy against two human pancreatic tumor cell lines in this model. These cell lines were transduced with the green fluorescent protein, enabling high-resolution visualization of tumor and metastatic growth in vivo. The DX-8951f studies included both an early and advanced cancer model. In the early model, using the human pancreatic cancer lines MIA-PaCa-2 and BxPC-3, treatment began when the orthotopic primary tumor was approximately 7 mm in diameter. DX-8951f was significantly effective against both MIA-PaCa-2 and BxPC-3. In contrast, 2', 2'-difluorodeoxycytidine (gemcitabine), the standard treatment for pancreatic cancer, did not have significant efficacy against MIA-PaCa-2. Although gemcitabine showed significant activity against BxPC-3 primary tumor growth, it was not effective on metastasis. In the model of advanced disease, using BxPC-3, treatment started when the orthotopic primary tumor was 13 mm in diameter. DX-8951f was significantly effective in a dose-response manner on the BxPC-3 primary tumor. DX-8951f also demonstrated antimetastatic activity in the late-stage model, significantly reducing the incidence of lymph node metastasis while eliminating lung metastasis. In contrast, gemcitabine was only moderately effective against the primary tumor and ineffective against metastasis at both sites in the late-stage model. Therefore, DX-8951f was highly effective against primary and metastatic growth in this very difficult-to-treat disease and showed significantly higher efficacy than gemcitabine, the standard treatment of pancreatic cancer. DX-8951f, therefore, has important clinical promise and has more positive features than the currently used camptothecin analogue CPT-11, which requires metabolic activation and is toxic.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
欣喜安卉发布了新的文献求助30
刚刚
z泽泽发布了新的文献求助10
刚刚
qingzheng1019完成签到,获得积分10
刚刚
1秒前
柚子完成签到 ,获得积分10
1秒前
So完成签到,获得积分10
1秒前
科研通AI6.2应助不加糖采纳,获得10
2秒前
好好看文献完成签到,获得积分10
2秒前
2秒前
Twonej应助渝州人采纳,获得30
2秒前
2秒前
鹤轩发布了新的文献求助10
2秒前
传奇3应助正直的雨泽采纳,获得10
2秒前
ying发布了新的文献求助20
3秒前
隐形元绿发布了新的文献求助10
3秒前
Baccano完成签到,获得积分10
4秒前
DUWEI应助sun采纳,获得10
4秒前
orixero应助拼搏尔风采纳,获得10
4秒前
4秒前
温暖依琴完成签到,获得积分10
5秒前
taoxuanran完成签到,获得积分10
5秒前
5秒前
Singularity应助郑安梅采纳,获得10
5秒前
6秒前
无花果应助lx208946547采纳,获得10
6秒前
小南风发布了新的文献求助10
6秒前
电化学小生完成签到,获得积分10
6秒前
6秒前
6秒前
上官若男应助吾皇采纳,获得10
7秒前
7秒前
lynn发布了新的文献求助10
7秒前
Cheryl发布了新的文献求助10
7秒前
许锐完成签到 ,获得积分20
7秒前
7秒前
QQQ完成签到,获得积分10
7秒前
7秒前
欣喜安卉完成签到,获得积分10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Lewis’s Child and Adolescent Psychiatry: A Comprehensive Textbook Sixth Edition 2000
Cronologia da história de Macau 1600
Treatment response-adapted risk index model for survival prediction and adjuvant chemotherapy selection in nonmetastatic nasopharyngeal carcinoma 1000
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 1000
BRITTLE FRACTURE IN WELDED SHIPS 1000
Toughness acceptance criteria for rack materials and weldments in jack-ups 800
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 计算机科学 化学工程 生物化学 物理 复合材料 内科学 催化作用 物理化学 光电子学 细胞生物学 基因 电极 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6207340
求助须知:如何正确求助?哪些是违规求助? 8033664
关于积分的说明 16734168
捐赠科研通 5298094
什么是DOI,文献DOI怎么找? 2822918
邀请新用户注册赠送积分活动 1801915
关于科研通互助平台的介绍 1663396